Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Trinity Capital Q2 EPS $0.38 Beats $0.32 Estimate

Trinity Capital (NASDAQ:TRIN) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.32 by 18.75 percent.

byBenzinga Newsdesk

August 5, 2021

1 minute read

Trinity Capital (NASDAQ:TRIN) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.32 by 18.75 percent.

RBC Capital Maintains Outperform on Waste Connections, Raises Price Target to $147

By Benzinga Newsdesk

Today, 10:40 PM

RBC Capital analyst Walter Spracklin maintains Waste Connections (NYSE:WCN) with a Outperform and raises the price target from $139 to $147.

TSX:WCN

Dare Bioscience Q3 EPS $(0.08) Beats $(0.12) Estimate. Cash And Cash Equivalents Of $40.4M

By Benzinga Newsdesk

Today, 10:40 PM

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.12) by 33.33 percent. This is a 55.56 percent increase over losses of $(0.18) per share from

DARE

FDA
News

Why Moderna Shares Continue To Climb Higher Today

By Adam Eckert

Today, 10:40 PM

Moderna Inc (NASDAQ: MRNA) is trading higher on continued strength Monday after the U.S. Food and Drug Administration last week authorized booster doses of the company's COVID-19 vaccine in the US for adults 18 and older.

MRNA

News

CIRCOR Files Form 12b-25 And Announces Review Of Potential Strategic Alternatives

By Bill Haddad

Today, 10:40 PM

CIRCOR International, Inc. (NYSE:CIR) (“CIRCOR” or “the Company”), one of the world’s leading providers of mission critical flow control products and services for the Industrial and

CIR

Trinity Capital Q2 EPS $0.38 Beats $0.32 Estimate

Related Posts

RBC Capital Maintains Outperform on Waste Connections, Raises Price Target to $147

Dare Bioscience Q3 EPS $(0.08) Beats $(0.12) Estimate. Cash And Cash Equivalents Of $40.4M

Why Moderna Shares Continue To Climb Higher Today

CIRCOR Files Form 12b-25 And Announces Review Of Potential Strategic Alternatives